
Linde Tops Revenue and Adjusted EPS Estimates as Sales Reach $9.4 Billion
The company guided full-year 2026 adjusted EPS to $17.82 to $17.92, and fourth-quarter adjusted EPS to $4.40 to $4.50.
Linde Plc · Nasdaq · Industrial Inorganic Chemicals

The company guided full-year 2026 adjusted EPS to $17.82 to $17.92, and fourth-quarter adjusted EPS to $4.40 to $4.50.
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Aug. 18, 2026 | Paula Rosput Reynolds director | Bought | 100 | $479.12 | $47,912 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedLinde Q3 2026 adjusted EPS $4.59 beats $4.52 consensus on $9.4 billion sales; Q4 guidance above consensus while full-year guidance midpoint $17.87 is in line with $17.88
Results of operations and financial condition · Financial statements and exhibits
Submission of matters to a vote of security holders · Financial statements and exhibits